Aspirin versus clopidogrel after percutaneous coronary intervention

被引：1
|
作者：
Pareek, Manan [1 ]
Byrne, Christina [2 ]
机构：
[1] Yale New Haven Med Ctr, Yale Sch Med, Dept Cardiol, New Haven, CT 06510 USA
[2] Bispebjerg & Frederiksberg Hosp, Dept Cardiol, Copenhagen, Denmark
来源：
LANCET | 2021年 / 398卷 / 10312期
关键词：
HOST-EXAM; MONOTHERAPY;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1685 / 1685
页数：1
相关论文
共 50 条
  • [21] Platelet Inhibition with Ticagrelor versus Clopidogrel in Diabetic Patients after Percutaneous Coronary Intervention for Chronic Coronary Syndromes
    Liu, Zhenyu
    Tian, Ran
    Wang, Yang
    Chen, Qian
    Li, Jingyi
    Xu, Lihong
    Zhang, Shuyang
    THROMBOSIS AND HAEMOSTASIS, 2020, 120 (08) : 1221 - 1229
  • [22] The safety and efficacy of indobufen or aspirin combined with clopidogrel in patients with acute myocardial infarction after percutaneous coronary intervention
    Dai, Wen-Bo
    Ren, Jia-Yi
    Hu, Su-Tao
    Zhang, Yu-Kun
    Gu, Tian-Shu
    Wu, Xue
    Zhang, Jing-Kun
    Che, Jing-Jin
    Ma, Xiang-Hong
    Liu, Tong
    Li, Guang-Ping
    Chen, Kang-Yin
    PLATELETS, 2024, 35 (01)
  • [23] Ticagrelor versus Clopidogrel in Elective Percutaneous Coronary Intervention : The Alpheus Trial
    Silvain, Johanne
    Cayla, Guillaume
    Beygui, Farzin
    Range, Gregoire
    Motovska, Zuzana J.
    Dillinger, Jean Guillaume
    Boueri, Ziad
    Brunel, Philippe
    Lhermusier, Thibault
    Pouillot, Christophe
    Christiaens, Luc
    Boccara, Franck
    Labeque, Jean-Noel
    Georges, Jean-Louis
    Bellemain-Appaix, Anne
    Hauguel-Moreau, Marie
    Le Breton, Herve
    Saint-Etienne, Christophe
    Caussin, Christophe
    Guedeney, Paul
    El Kasty, Mohamad
    Laredo, Mikael Laredo
    Dumaine, Raphaelle
    Ducrocq, Gregory
    Collet, Jean-Philippe
    Lattuca, Benoit
    Blanchart, Katrien
    Kala, Petr
    Vicaut, Eric
    Montalescot, Gilles
    CIRCULATION, 2020, 142 (24) : E485 - E486
  • [24] CLOPIDOGREL VERSUS PRASUGREL IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
    Zeb, Shah
    Shah, Ibrahim
    Adil, Mohammad
    Ali, Jabar
    Jan, Hikmatullah
    Gul, Adnan Mahmood
    Hafizullah, Mohammad
    PAKISTAN HEART JOURNAL, 2016, 49 (03): : 107 - 112
  • [25] Triflusal versus aspirin in conjunction with clopidogrel in patients undergoing percutaneous coronary intervention with the drug-eluting stent.
    Rha, SW
    Suh, SY
    Kim, JW
    Park, CG
    Seo, HS
    Oh, DJ
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (8B): : 57D - 57D
  • [26] Clopidogrel and percutaneous coronary intervention - Reply
    Mehta, SR
    Zhao, F
    Yusuf, S
    LANCET, 2002, 359 (9301): : 169 - 169
  • [27] Resistance to antiplatelet drugs (aspirin, clopidogrel) in patients undergoing elective percutaneous coronary intervention
    Sulimov, V. A.
    Moroz, E. V.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2012, 8 (01) : 23 - 30
  • [28] Aspirin Plus Clopidogrel Versus Aspirin Alone After Coronary Artery Bypass Grafting
    Bakaeen, Faisal G.
    Chu, Danny
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (06)
  • [29] Comparison of the different methods of monitoring the effect of aspirin and clopidogrel in patients with percutaneous coronary intervention
    Smejkal, P.
    Kala, P.
    Zavrelova, J.
    Poloczek, M.
    Spinar, J.
    Penka, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 901 - 901
  • [30] Clopidogrel plus indobufen in acute coronary syndrome patients with hypersensitivity to aspirin undergoing percutaneous coronary intervention
    Barilla, Francesco
    Pulcinelli, Fabio Maria
    Mangieri, Enrico
    Torromeo, Concetta
    Tanzilli, Gaetano
    Dominici, Tania
    Pellicano, Mariano
    Paravati, Vincenzo
    Acconcia, Maria Cristina
    Gaudio, Carlo
    PLATELETS, 2013, 24 (03) : 183 - 188
12345